New Progress on the Role of Gut Microbiota in the Incidence and Prevention of Liver Diseases

7,033
Total downloads
33k
Total views and downloads

Articles

CORRECTION

Published on 07 Aug 2025

Correction: Exploring the mechanisms of tetrahydrocurcumin in ameliorating nonalcoholic steatohepatitis based on network pharmacology and gut microbiota analysis in vivo and in vitro

Keyu Chen
Jianbo Wang
Shuang Luo
Yunyun Quan
Ping Wei
Jiali Fu
Jiali Ma
Yuying Yang
Yunten Liu
Zhichong Gao

doi 10.3389/fmicb.2025.1656225

290 views

ORIGINAL RESEARCH

Accepted on 31 Jul 2025

Rivaroxaban alleviates hepatic sinusoidal obstruction syndrome in mice by modulating the gut microbiota and inhibiting the PI3K/Akt signaling pathway

Wencheng Liu
Yanbin Cheng
Junlin Xia
Lixuan Sang
Qingyu Wei
Bing Chang
Quansheng Li

doi 10.3389/fmicb.2025.1607131

146 views

ORIGINAL RESEARCH

Accepted on 28 Jul 2025

Elucidating the Gut Microbiota-Driven Crosstalk: Mechanistic Interplay of Lobetyolin in Coordinating Cholesterol Homeostasis and Anti-Inflammatory Pathways in Hyperlipidemic Mice Models

Guofeng Duan
Yuning Zhang
Siyuan Liu
Siqi Wang
Jinjia Liu
Lijuan Li
Lina Lai

doi 10.3389/fmicb.2025.1625211

145 views

ORIGINAL RESEARCH

Accepted on 10 Jul 2025

Integrative Network Pharmacology, Metabolomics and Gut Flora Studies Reveal Mechanisms of Action of Rhododendron molle (Blume) G. Don to Ameliorate Liver Injury

Xiaolei Jiang
Yafeng Zhuag
Tiancheng Meng
Tianwei Meng
Xinghua Li
Dan He
Hongyu Meng
Chang Hong

doi 10.3389/fmicb.2025.1570229

136 views

ORIGINAL RESEARCH

Published on 01 Jul 2025

Galla chinensis alleviated liver damage induced by acetaminophen by regulating intestinal microbiota

Xiaocong Li
Jiadong Chen
Chang Xu
Yong Li
Kun Li

doi 10.3389/fmicb.2025.1589946

890 views

ORIGINAL RESEARCH

Published on 19 Jun 2025

Analysis of gut and circulating microbiota characteristics in patients with liver cirrhosis and portal vein thrombosis

Ping Qi
Xu-xu Yang
Cun-kai Wang
Wei Sang
Wei Zhang
Yun Bai

doi 10.3389/fmicb.2025.1597145

1,398 views

MINI REVIEW

Published on 19 Jun 2025

Gut microbiota and the “gut-liver-kidney axis” theory: from mechanisms to therapeutics

Dai-Liang Fei
Ying Liu
Jia Liu
Ze Yu
Jin-Liang Dong

doi 10.3389/fmicb.2025.1554458

1,509 views

ORIGINAL RESEARCH

Published on 17 Jun 2025

Exploring the mechanisms of tetrahydrocurcumin in ameliorating nonalcoholic steatohepatitis based on network pharmacology and gut microbiota analysis in vivo and in vitro

Keyu Chen
Jianbo Wang
Shuang Luo
Yunyun Quan
Ping Wei
Jiali Fu
Jiali Ma
Yuying Yang
Yunten Liu
Zhichong Gao

doi 10.3389/fmicb.2025.1576221

1,097 views

ORIGINAL RESEARCH

Published on 15 May 2025

Enterotype-stratified gut microbial signatures in MASLD and cirrhosis based on integrated microbiome data

Heng Yuan
Junyu Zhou
Xuangao Wu
Shiwei Wang
Sunmin Park

doi 10.3389/fmicb.2025.1568672

1,803 views

REVIEW

Published on 02 May 2025

The role of intestinal microbiota and its metabolites in the occurrence and intervention of obesity

Yang Gao
Wenhui Liu
Xue Ma
Min Xue
Yingying Li
Shanshan Bi
Huan Leng

doi 10.3389/fmicb.2025.1559178

1,879 views

REVIEW

Published on 25 Apr 2025

Unlocking the gut-liver axis: microbial contributions to the pathogenesis of metabolic-associated fatty liver disease

Mykhailo Buchynskyi
Iryna Kamyshna
Iryna Halabitska
Pavlo Petakh
Oksana Kunduzova
Valentyn Oksenych
Oleksandr Kamyshnyi

doi 10.3389/fmicb.2025.1577724

2,797 views

CORRECTION

Published on 23 Apr 2025

Corrigendum: Characterization of the hepatic flora and metabolome in nonalcoholic fatty liver disease

Hua Jiang
Hui Wang
Yangfan Guo
Yankun Zhu
Hui Dai
Chenchen Liang
Jianpeng Gao

doi 10.3389/fmicb.2025.1591065

770 views

Share on

Frontiers in Microbiology

Microorganisms in Vertebrate Digestive Systems

Impact

33kTopic views
25kArticle views
7,033Article downloads

View impact

Articles

Correction: Exploring the mechanisms of tetrahydrocurcumin in ameliorating nonalcoholic steatohepatitis based on network pharmacology and gut microbiota analysis in vivo and in vitro

Rivaroxaban alleviates hepatic sinusoidal obstruction syndrome in mice by modulating the gut microbiota and inhibiting the PI3K/Akt signaling pathway

Elucidating the Gut Microbiota-Driven Crosstalk: Mechanistic Interplay of Lobetyolin in Coordinating Cholesterol Homeostasis and Anti-Inflammatory Pathways in Hyperlipidemic Mice Models

Integrative Network Pharmacology, Metabolomics and Gut Flora Studies Reveal Mechanisms of Action of Rhododendron molle (Blume) G. Don to Ameliorate Liver Injury

Galla chinensis alleviated liver damage induced by acetaminophen by regulating intestinal microbiota

Analysis of gut and circulating microbiota characteristics in patients with liver cirrhosis and portal vein thrombosis

Gut microbiota and the “gut-liver-kidney axis” theory: from mechanisms to therapeutics

Exploring the mechanisms of tetrahydrocurcumin in ameliorating nonalcoholic steatohepatitis based on network pharmacology and gut microbiota analysis in vivo and in vitro

Enterotype-stratified gut microbial signatures in MASLD and cirrhosis based on integrated microbiome data

The role of intestinal microbiota and its metabolites in the occurrence and intervention of obesity

Unlocking the gut-liver axis: microbial contributions to the pathogenesis of metabolic-associated fatty liver disease

Corrigendum: Characterization of the hepatic flora and metabolome in nonalcoholic fatty liver disease

Frontiers in Microbiology

Microorganisms in Vertebrate Digestive Systems